1-4 of 4
Christine M. Hartford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients

Eric R. Gamazon, Jatinder K. Lamba, Stanley Pounds, Amy L. Stark, Heather E. Wheeler, Xueyuan Cao, Hae K. Im, Amit K. Mitra, Jeffrey E. Rubnitz, Raul C. Ribeiro, Susana Raimondi, Dario Campana, Kristine R. Crews, Shan S. Wong, Marleen Welsh, Imge Hulur, Lidija Gorsic, Christine M. Hartford, Wei Zhang, Nancy J. Cox, M. Eileen Dolan
Journal: Blood
Blood (2013) 121 (21): 4366–4376.
https://doi.org/10.1182/blood-2012-10-464149
Published: 2013
Includes: Supplemental data
Journal Articles

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity

Clinical Trials & Observations
Christine M. Hartford, Shiwei Duan, Shannon M. Delaney, Shuangli Mi, Emily O. Kistner, Jatinder K. Lamba, R. Stephanie Huang, M. Eileen Dolan
Journal: Blood
Blood (2009) 113 (10): 2145–2153.
https://doi.org/10.1182/blood-2008-05-154302
Published: 2009
Includes: Supplemental data
Journal Articles

Genetic Determinants of Susceptibility to Cytarabine Arabinoside.

Christine M. Hartford, MD, Shiwei Duan, PhD, Emily Kistner, PhD, M.E. Dolan, PhD
Journal: Blood
Blood (2007) 110 (11): 227.
https://doi.org/10.1182/blood.V110.11.227.227
Published: 2007
Journal Articles

Genome Scan for Therapy-Related Leukemia.

Christine M. Hartford, MD, Wenjian Yang, PhD, Cheng Cheng, PhD, Stanley Pounds, PhD, Wei Liu, PhD, Xiaoping Su, PhD, Geoffrey Neale, PhD, Susana C. Raimondi, PhD, Ching-Hon Pui, MD, Mary V. Relling, PharmD
Journal: Blood
Blood (2005) 106 (11): 3254.
https://doi.org/10.1182/blood.V106.11.3254.3254
Published: 2005